Home

CVRx, Inc. - Common Stock (CVRX)

11.58
-0.69 (-5.62%)
NASDAQ · Last Trade: Apr 5th, 3:20 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to CVRx, Inc. - Common Stock (CVRX)

Abbott Laboratories ABT -5.46%

Abbott Laboratories competes with CVRx primarily in the field of cardiovascular disease management with its heart failure devices and monitoring systems. They have a strong R&D pipeline and a robust marketing strategy that enhances their product visibility. Abbott's diversified product lines and established healthcare relationships give them a competitive advantage, making it challenging for CVRx to penetrate certain segments of the market.

Boston Scientific BSX -8.93%

Boston Scientific develops and manufactures a wide array of medical devices, including those used in cardiac rhythm management and heart failure therapies. They compete with CVRx by offering innovative technologies and have established a strong reputation for high-quality products. Boston Scientific's extensive portfolio allows them to bundle offerings, providing a broader range of treatment options than CVRx, thus maintaining a competitive edge.

Cameron Health, Inc. (a division of Boston Scientific)

Cameron Health is known for its innovative technologies for arrhythmias and heart rhythm management, which compete indirectly with CVRx’s offerings. While Cameron Health is a smaller division compared to Boston Scientific, they leverage the larger company's resources to enhance development of cardiac devices, including those for heart failure management. Their innovation in specific technology segments helps them maintain competitiveness. However, they are not as widely recognized as some of the larger competitors listed.

Medtronic MDT -5.70%

Medtronic is a global leader in medical technology and offers various cardiovascular products, including devices for heart failure treatment. They compete with CVRx in the therapeutic area for patients with heart disease. Medtronic has a vast distribution network and brand recognition, which gives them a significant competitive advantage over CVRx in terms of market reach and resources for research and development.

Zoll Medical Corporation

Zoll Medical specializes in advanced resuscitation and critical care technologies, including devices that may serve cardiovascular patients. Their competition with CVRx arises from their focus on device innovation and clinical outcomes in emergency and cardiac settings. Although they cater to a slightly different niche within the broader cardiovascular field, Zoll's reputation for impactful patient outcomes can be seen as a competitive edge where their devices are applicable.